Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism

por Sanchez Spitman, A. B., Moes, D. J. A. R., Gelderblom, H., Dezentje, V. O., Swen, J.J., Guchelaar, H. J.
Publicado 2017

Genetic polymorphisms of 3′-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy

por Sanchez-Spitman, A. B., Dezentjé, V. O., Swen, J. J., Moes, D. J. A. R., Gelderblom, H., Guchelaar, Henk-Jan
Publicado 2018

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse

por Sanchez-Spitman, A. B., Swen, J. J., Dezentjé, V. O., Moes, D. J. A. R., Gelderblom, H., Guchelaar, H. J.
Publicado 2021

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

por Dezentjé, V. O., Opdam, F. L., Gelderblom, H., Hartigh den, J., Van der Straaten, T., Vree, R., Maartense, E., Smorenburg, C. H., Putter, H., Dieudonné, A. S., Neven, P., Van de Velde, C. J. H., Nortier, J. W. R., Guchelaar, H.-J.
Publicado 2015